Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Mai 22, 2026
Le scientifique en chef d'Immunome a réduit sa participation. Une soumission prévue à la FDA vous en dit plus
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
The panel largely agrees that Immunome's current valuation is frothy, with a market cap of $2.4 billion on $6.94 million …
Avec un rendement de 5,6 %, Verizon est-elle une excellente action à dividendes à acheter ?
Yielding 5.6%, Is Verizon an Excellent Dividend Stock to Buy?
The panel consensus is that Verizon's (VZ) 5.6% yield is not sustainable given its high capex requirements, stagnant top-line growth, …
La volatilité boursière augmente : 1 action spectaculaire que vous pouvez acheter à prix réduit aujourd'hui
Stock Market Volatility is Increasing: 1 Spectacular Stock You Can Buy at a Bargain Price Today
The panel consensus is that the article is promotional and lacks concrete valuation metrics to support its 'bargain' claim on …
Le Directeur Médical de Maze Therapeutics a Vendu 100 % de Ses Titres Directs. Voici ce que Cela Signifie pour les Investisseurs.
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.
The panel's discussion centered around the liquidation of 100% of MAZE Therapeutics' CMO's direct holdings, with a focus on the …
3 actions à haut rendement à acheter avec 1 000 $ et à conserver à jamais
3 High-Yield Stocks to Buy With $1,000 and Hold Forever
The panel consensus is bearish on the 'hold forever' strategy for BNS, O, and EPD, citing macro-sensitivity, tax headwinds, and …
Analyse boursière d'UnitedHealth : opportunité d'achat générationnelle ou couteau qui tombe à éviter ?
UnitedHealth Stock Analysis: Generational Buying Opportunity or a Falling Knife to Avoid?
The panel consensus is that UNH's current valuation is uncertain due to elevated medical loss ratios, Medicare Advantage reimbursement cuts, …
1 Action Sous-Évaluée Secrète que Vous Pouvez Acheter et Dont Personne ne Parle
1 Secret Undervalued Stock You Can Buy That Nobody is Talking About
The panel consensus is that the article is a marketing ploy rather than a genuine investment opportunity. The unnamed 'indispensable …
Analyse des actions CoreWeave : acheter ou vendre cette action d'IA soutenue par Nvidia ?
CoreWeave Stock Analysis: Buy or Sell This Nvidia-Backed AI Stock?
The panel consensus is that CoreWeave (CRWV) faces significant risks, with key concerns being high leverage, vulnerability to Nvidia price …
La Disparition Du Procès Devant Jury
The Demise Of Trial By Jury
The panel discusses the potential impact of the UK's proposed 'swift courts' on the legal and insurance sectors. While some …
Le péage de Téhéran pour le détroit d'Ormuz divise les pays en 3 catégories
Tehran's Toll Booth For Hormuz Strait Divides Countries Into 3 Categories
The panel agrees that Iran's 'Tehran Toll Booth' initiative will increase transit costs and risks, potentially leading to a permanent …
Moins de la moitié des travailleurs de la santé ont reçu un vaccin COVID-19 mis à jour : CDC
Less Than Half Of Health Care Workers Received An Updated COVID-19 Vaccine: CDC
The panel agrees that COVID-19 vaccination rates among healthcare workers remain low (40.2%) despite their frontline exposure, with mandates being …
Deutsche Bank voit des risques de coûts et de demande, réduit General Mills (GIS)
Deutsche Bank Sees Cost and Demand Risks, Trims General Mills (GIS)
Analysts express bearish sentiments towards GIS due to macro headwinds, margin compression, and potential dividend risk. However, there's disagreement on …